Genetic Technologies embraces global vision for genomic-integrated healthcare | News Direct

Genetic Technologies embraces global vision for genomic-integrated healthcare

Genetic Technologies Ltd
News release by Genetic Technologies Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon Melbourne, Victoria | May 26, 2023 03:00 PM Eastern Daylight Time

Genetic Technologies Ltd (ASX:GTG) CEO Simon Morriss is back with Proactive’s Elisha Newell to outline the company’s latest endeavours in the predictive genetics space. Lauded as a pioneer in clinical genetics tech, GTG is working on early-stage tools that help clinicians and patients proactively manage their health. Morriss says the company’s product suite is geared towards personalised, non-invasive testing and risk assessments, all designed to accelerate a global transition to genomic-integrated healthcare.

 

 

Contact Details

 

Proactive Investors

 

Jonathan Jackson

 

+61 413 713 744

 

jonathan@proactiveinvestors.com

project media

Tags

ProactiveInvestorsGeneticTechnologiesASXDiagnosticGeneType